Deprecated: Creation of dynamic property WhitelabelOptions::$_title is deprecated in /home/grassnews/public_html/wp-content/themes/zox-news/admin/admin-page.php on line 79
Drive Shack Announces First Quarter 2019 Results and Declares Second Quarter 2019 Preferred Stock Dividends – GrassNews
Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Drive Shack Announces First Quarter 2019 Results and Declares Second Quarter 2019 Preferred Stock Dividends



Reading Time: 9 minutes

Company announces 1 new Drive Shack location and confirms three new
venue openings in 2019

Has closed sales of 18 golf courses for $132 million to date

NEW YORK–(BUSINESS WIRE)–Drive Shack Inc. (NYSE: DS), an owner and operator of golf entertainment
and dining venues and traditional golf courses, today announced
financial results for its first quarter ended March 31, 2019.

Business Highlights

  • Drive Shack
    • Entered into new partnership with Trackman, the leading provider
      of radar-based ball tracking
    • Announced Drive Shack location in Minneapolis, MN
    • Hired Head of Architecture to lead design of future Drive Shack
    • Drive Shack Orlando, which opened in April 2018, generated $1.7
      million of revenue in Q1 2019, up 11% compared to Q4
    • Raleigh, Richmond and West Palm Beach locations on track to open
      in the second half of 2019
  • American Golf Corporation
    • Total golf proceeds of $132 million from the sale of 18 courses
    • American Golf Corporation Q1 2019 revenue generation of $52 million
    • Grew public course The Players Club Members by 14% and private
      course average membership Dues by 2%, on a same-store basis over
      prior year
  • Company adds 2 new members, Virgis Colbert and Ben Crane, to the Board
    of Directors

“We are pleased to see Drive Shack Orlando’s improved performance
compared to the prior quarter. We are on track to open Raleigh, Richmond
and West Palm Beach in the second half of this year, and we are thrilled
to announce a new Drive Shack location in Minneapolis, MN,” said Ken
May, Chief Executive Officer. “We continue to refine our blueprint for
site-level operations, using Orlando as the test kitchen for new ideas,
ahead of the next three site openings. Guest experience is the priority.
The implementation of Trackman ball tracking technology at all of our
sites and the menu redesign rollout are just a couple ways we are
enhancing the experience.”

“We continue to make strides optimizing our American Golf portfolio and
expect the stabilized business to generate $175M in total revenue by
2020. In terms of course sales, we generated $132 million in gross
proceeds from the sale of 18 owned golf courses and expect approximately
$42 million additional gross proceeds across 5 courses in contract or
LOI. We will use these proceeds to fund our entertainment golf business
and expect to have 20 sites open by 2022,” said David Hammarley, Chief
Financial Officer. “Overall, I’m confident that our world class
operating team will execute on our business plan and hit the financial
targets we’ve set. With our team and operating costs largely in place,
we expect overall company G&A costs to scale down to 5-10% of total
revenues over the next few years as the business scales up.”


Since the last earnings release on March 14, 2019, the Company signed a
new location in Minneapolis, MN. The Company plans to open 3 new Drive
Shack sites in Raleigh, NC, Richmond, VA, and West Palm Beach, FL in the
second half of 2019.

Board Members

The management team is excited to announce the addition of Virgis
Colbert and Ben Crane to The Board of Directors to further drive the
growth of the business.


Virgis Colbert, who will also serve on the Board’s Audit and
Compensation Committees, has significant operational experience
including Executive Vice President of Worldwide Operations at Miller
Brewing Company. Mr. Colbert’s business acumen and proven track record
earned him roles as the Director of the NASDAQ exchange and a Board seat
on several Fortune 500 companies. He is a lifetime member of the
National Association for the Advancement of Colored People and was named
a national honorary member of the 100 Black Men of America. As an avid
fan of golf, Virgis is a member of two of the most prestigious golf
clubs in America.

Ben Crane, who will also serve on the Board’s Compensation Committee, is
an American professional golfer, who has been a member of the PGA tour
since December 2001 and captured five PGA tour wins. Mr. Crane is
actively involved in several charities, which includes founding the
Crane Foundation, whose mission is to help others reach new heights and
levels of achievement and spirituality in their lives. His charity
supports several other nonprofits including the College Golf Fellowship,
Forward Edge International, H.O.P.E Farm Inc., Love146 Inc., the St.
Bernard Project and Young Life.

Sarah Watterson resigned from the Board on May 7, 2019 to focus on other
professional pursuits. “We’re grateful for Sarah’s contributions in
creating Drive Shack. I wish her all the best, and I am confident that
her leadership will be greatly valued in future endeavors,” said Ken May.

Financial Outlook

Our FY 2019 expectations and stabilized targets are as follows:

  • Drive Shack Orlando site is targeted to break even from a cash flow
    perspective in 2019 and continue to ramp up its revenues and cash flow
    generation in 2020 onwards
  • Raleigh, Richmond, and West Palm Beach planned to open in the second
    half of 2019 and expect to generate revenues and EBITDA consistent
    with target unit economics starting in 2020
  • Plan to open 3 to 5 new sites in 2020 and 5 to 10 sites in 2021 and
  • Targeting 20+ open sites in 2022
  • Stabilized target Drive Shack entertainment unit economics:
    • Cost to build between $20 to $35 million across the varying
      markets and relevant venue formats
    • Top-line revenues anticipated to be $15 to $25 million with
      targeted EBITDA margins of approximately 25%-30%
  • Stabilized traditional golf business to generate revenue of
    approximately $175 million and target annual course-level EBITDA
    margins of 15-20% in 2020 and beyond
  • Complete the remaining short-term course sales by end of 2019 with
    total gross proceeds of approximately $175 million from 24 of the 26
    owned courses
    • Continue to explore the monetization of the remaining 2 owned
      courses in 2019
  • Target total Company G&A of 5-10% of total Revenue by 2022

Preferred Stock Dividends

The Company will pay dividends on July 31, 2019 to holders of record of
preferred stock on July 1, 2019, for the period beginning May 1, 2019
and ending July 31, 2019, in an amount equal to $0.609375, $0.503125 and
$0.523438 per share on the 9.750% Series B, 8.050% Series C and 8.375%
Series D preferred stock, respectively.

Financial Results

First Quarter 2019 compared to the First Quarter 2018 ($ in
thousands, except for per share data):

Three Months Ended
March 31,
2019     2018
Total revenues $ 53,952   $ 66,660  
Loss applicable to common stockholders $ (15,995 ) $ (17,690 )
Basic $ (0.24 ) $ (0.26 )
Diluted $ (0.24 ) $ (0.26 )

Conference Call Today

Management will hold a conference call to discuss these results today at
9:00 a.m. Eastern Time. The conference call can be accessed over the
phone by dialing 1-866-913-6930 (from within the U.S.) or 1-409-983-9881
(from outside of the U.S.) ten minutes prior to the scheduled start of
the call; please reference conference ID “8038894.”


A copy of the earnings release will be posted to the Investor Relations
section of Drive Shack Inc.’s website,

A simultaneous webcast of the conference call will be available to the
public on a listen-only basis at
Please allow extra time prior to the call to visit the website and
download any necessary software required to listen to the internet

A telephonic replay of the conference call will also be available two
hours following the call’s completion through 11:30 P.M. Eastern Time on
Friday, May 24, 2019 by dialing 1-800-585-8367 (from within the U.S.) or
1-404-537-3406 (from outside of the U.S.); please reference conference
ID “8038894.”

Additional Information

For additional information that management believes to be useful for
investors, please refer to the presentation posted on the Investor
Relations section of the Company’s website,
For consolidated information, please refer to the Company’s most recent
Quarterly Report on Form 10-Q or Annual Report on Form 10-K, which
are available on the Company’s website,


About Drive Shack

Drive Shack Inc. is a leading owner and operator of golf-related leisure
and entertainment businesses.

Forward-Looking Statements: Certain items in this Press Release
may constitute forward looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, including, but not
limited to, statements regarding Drive Shack Inc.’s (NYSE: DS; “DS Inc.”
or the “Company” and “we,” “us” and “our,” as applicable) (a) statements
relating to returns on our investments, (b) anticipated future sales of
selected owned golf properties, including without limitation statements
relating to the timing and amount of anticipated proceeds, (c) our plans
and expectations to optimize the operation of, and grow, our existing
leased and managed golf properties, (d) redeployment of cash from our
generated liquidity, (e) targeted multiples, yields and returns, (f) our
ability to terminate or restructure leases and (g) the Company’s current
business plan and expectations relating to our Drive Shack venues,
including (i) the number of venues that we may be able to develop, (ii)
timing and frequency for opening venues, (iii) financial performance of
these venues and capital expenditure costs, (iv) the growth of the golf,
golf entertainment, and eatertainment industry and business, and (v) our
ability to enhance technology. These statements are based on
management’s current expectations and beliefs and are subject to a
number of risks, trends and uncertainties that could cause actual
results to differ materially from those described in the forward-looking
statements, many of which are beyond our control. We cannot give any
assurances that management’s current expectations will be attained. For
a discussion of some of the risks and important factors that could cause
actual results to differ materially from such forward-looking
statements, see the sections entitled “Risk Factors” and “Management’s
Discussion and Analysis of Financial Condition and Results of
Operations” in the Company’s periodic reports filed with the Securities
and Exchange Commission (“SEC”), which are available on the Company’s
website (www.
In addition, new risks and uncertainties emerge from time to time, and
it is not possible to predict or assess the impact of every factor that
may cause actual results to differ from those contained in any
forward-looking statements. Accordingly, you should not place undue
reliance on any forward-looking statements contained in this Press
Release. Forward-looking statements speak only as of the date of this
Press Release. We expressly disclaim any obligation to release publicly
any updates or revisions to any forward-looking statements contained
herein to reflect any change in expectations with regard thereto or
change in events, conditions or circumstances on which any statement is

Past Performance; No Offer; No Reliance: Past performance is not
a reliable indicator of future results and should not be relied upon as
the basis for making an investment decision. This Press Release does not
constitute an offer to sell, or a solicitation of an offer to buy, any
security. Any such offer would only be made by means of formal offering
documents, the terms of which would govern in all respects. You should
not rely on this Press Release as the basis upon which to make any
investment decision.

The Company has not reconciled its EBITDA targets set forth in this
press release to net income (loss) or cash from operations, as items
that impact such measures are out of the Company’s control and/or cannot
be reasonably predicted. Accordingly, a reconciliation is not available
without unreasonable effort.


Cautionary Note regarding Estimated / Targeted Returns and Growth:
Targeted returns and growth represent management’s view and are
estimated based on current and projected future operating performance of
our location in Orlando and other targeted locations, comparable
companies in our industry and a variety of other assumptions, many of
which are beyond our control, that could prove incorrect. As a result,
actual results may vary materially with changes in our liquidity or
ability to obtain financing, changes in market conditions and additional
factors described in our reports filed with the SEC, which we encourage
you to review. We undertake no obligation to update these estimates. See
above for more information on forward-looking statements.

Consolidated Balance Sheets

March 31, 2019 December 31, 2018
Current assets
Cash and cash equivalents $ 49,599 $ 79,235
Restricted cash 3,365 3,326
Accounts receivable, net 5,635 7,518
Real estate assets, held-for-sale, net 51,931 75,862
Real estate securities, available-for-sale 3,007 2,953
Other current assets   20,331     20,505  
Total current assets 133,868 189,399
Restricted cash, noncurrent 258 258
Property and equipment, net of accumulated depreciation 157,636 132,605
Operating lease right-of-use assets 223,278
Intangibles, net of accumulated amortization 20,952 48,388
Other investments 22,956 22,613
Other assets   5,043     8,684  
Total assets $ 563,991   $ 401,947  
Liabilities and Equity
Current liabilities
Obligations under finance leases $ 6,790 $ 5,489
Membership deposit liabilities 8,834 8,861
Accounts payable and accrued expenses 37,740 45,284
Deferred revenue 14,738 18,793
Real estate liabilities, held-for-sale 813 2,947
Other current liabilities   29,277     22,285  
Total current liabilities 98,192 103,659
Credit facilities and obligations under finance leases – noncurrent 13,185 10,489
Operating lease liabilities – noncurrent 190,229
Junior subordinated notes payable 51,198 51,200
Membership deposit liabilities, noncurrent 92,603 90,684
Deferred revenue, noncurrent 5,445 6,016
Other liabilities   3,076     5,232  
Total liabilities $ 453,928   $ 267,280  
Commitments and contingencies

Preferred stock, $0.01 par value, 100,000,000 shares authorized,

of 9.75% Series B Cumulative Redeemable Preferred Stock, 496,000
shares of 8.05%
Series C Cumulative Redeemable Preferred
Stock, and 620,000 shares of 8.375% Series
D Cumulative
Redeemable Preferred Stock, liquidation preference $25.00 per
issued and outstanding as of March 31, 2019 and
December 31, 2018

61,583 61,583

Common stock, $0.01 par value, 1,000,000,000 shares authorized,
67,027,104 and


67,027,104 shares issued and outstanding at March 31, 2019 and
December 31, 2018,

670 670
Additional paid-in capital 3,177,065 3,175,843
Accumulated deficit (3,131,133 ) (3,105,307 )
Accumulated other comprehensive income   1,878     1,878  
Total equity $ 110,063   $ 134,667  
Total liabilities and equity $ 563,991   $ 401,947  

Consolidated Statements of Operations

Three Months Ended
March 31,
2019     2018
Golf operations $ 44,706 $ 53,554
Sales of food and beverages   9,246     13,106  
Total revenues   53,952     66,660  
Operating costs
Operating expenses 47,723 57,379
Cost of sales – food and beverages 2,698 4,040
General and administrative expense 11,619 9,192
Depreciation and amortization 4,924 5,548
Pre-opening costs 1,179 1,556
Impairment 4,088 1,473
Realized and unrealized (gain) on investments       (242 )
Total operating costs   72,231     78,946  
Operating loss (18,279 ) (12,286 )
Other income (expenses)
Interest and investment income 344 446
Interest expense, net (2,153 ) (4,049 )
Other income (loss), net  


  (406 )
Total other income (expenses)   3,679     (4,009 )
Loss before income tax (14,600 ) (16,295 )
Income tax expense        
Net Loss (14,600 ) (16,295 )
Preferred dividends   (1,395 )   (1,395 )
Loss Applicable to Common Stockholders $ (15,995 ) $ (17,690 )
Loss Applicable to Common Stock, per share
Basic $ (0.24 ) $ (0.26 )
Diluted $ (0.24 ) $ (0.26 )
Weighted Average Number of Shares of Common Stock Outstanding
Basic   67,027,104     66,977,104  
Diluted   67,027,104     66,977,104  



For Investor Relations Inquiries:
Austin Pruitt
Shack Inc.

Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493


IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis




TORONTO and GLIL YAM, Israel, July 12, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IM Cannabis“), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated July 5, 2024, effective today the Company’s common shares (“Common Shares“) are trading on the Canadian Securities Exchange (the “CSE“) and Nasdaq Stock Market LLC (“NASDAQ“) on a 6:1 post-consolidated basis (the “Consolidation“).

The Company’s trading symbol remains “IMCC” on both the CSE and NASDAQ. The Company’s new CUSIP and ISIN numbers are 44969Q406 and CA44969Q4060, respectively.

After giving effect to the Consolidation, the Common Shares were reduced from 13,394,136 to 2,232,357 Common Shares. No fractional Common Shares were issued in connection with the Consolidation. Instead, all fractional Common Shares equal to or greater than one-half resulting from the Consolidation were rounded to the next whole number, otherwise, the fractional Common Share were cancelled. The exercise price and/or conversion price and number of Common Shares issuable under any of the Company’s outstanding convertible securities were proportionately adjusted in connection with the Consolidation.

Computershare Investor Services Inc., the Company’s registrar and transfer agent for the Common Shares, has mailed letters of transmittal to registered shareholders of record as of July 12, 2024 providing instructions for the exchange of their Common Shares as soon as practicable following the effective date. Registered shareholders may also obtain a copy of the letter of transmittal by accessing the Company’s SEDAR+ profile at Until surrendered, each Common Share certificate or direct registration system statement representing pre-consolidated Common Shares will represent the number of whole post-consolidated Common Shares to which the holder is entitled as a result of the Consolidation. No action is required by beneficial holders to receive post-consolidation Common Shares in connection with the Consolidation. Beneficial holders who hold their Common Shares through intermediaries (e.g., a broker, bank, trust company investment dealer or other financial institution) and who have questions regarding how the Consolidation will be processed should contact their intermediaries with respect to the Consolidation.

About IM Cannabis Corp. 


IM Cannabis (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IM Cannabis’ products throughout the entire value chain. In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements“). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to the Company amplifying its commercial and brand power to become a global high-quality cannabis player.

Forward-looking information is based on assumptions that may prove to be incorrect, including but not limited to: the Company’s ability to maintain the listing requirements of the CSE and NASDAQ; the Company’s ability to focus on Israel, Germany and Europe; the Company’s ability to realize upon the stated benefits of the partial legalization of cannabis in Germany; and the Company amplifying its commercial and brand power to become a global high-quality cannabis player. The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company’s ability to continue to meet the listing requirements of the CSE and NASDAQ; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical Herbs Ltd. (collectively, the “Group“) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East; the risk of the Company’s inability to capitalize upon the partial legalization of cannabis in Germany; and risks the Company will be unable to amplify its commercial and brand power and/or be unable to become a global high-quality cannabis player.


Please see the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report dated March 28, 2024, which is available on the Company’s issuer profile on SEDAR+ at and EDGAR at Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.

Logo –


Cision View original content:

Continue Reading


Legal Cannabis Market Share Value Projected to Reach USD 194.5 Billion, at 16.9% CAGR by 2034: Prophecy Market Insights



Covina, July 11, 2024 (GLOBE NEWSWIRE) — The study concludes that the global legal cannabis market size and share is expected to grow at a CAGR of 16.9% between 2024 and 2034. The market revenue of USD 47 Billion in 2024 is expected to grow up to USD 194.5 Billion by 2034.

Cannabis was an illicit drug before, but its legalization process is on fast track today in many nations around the globe, opening a multibillion-dollar market with huge growth potential. The said market is bifurcated into two categories: medical cannabis, used for the treatment of various diseases, and recreational cannabis, for fun and other purposes. Most marijuana consumers are young, especially millennials. Males use it more than females, while the level of consumption is also predicated by class and thereby affects the rate of consumption. Psychographics show that marijuana consumers are social, open to experiences, and concerned about health; the last two probably represent a broader moving trend to natural products and alternate medicine.

The legal cannabis market offers a huge amount of variety, starting from flowers to extracts and consumables like cookies and chocolate that can be applied topically on the skin. Concentrations are gaining their following and popularity because of their potency. Also very popular are the edibles—baked goods, particularly cookies, and sweets—that appeal to those who crave discreetness and effectiveness all at once in consumption.

Download a Free Sample Research Report with Latest Industry Insights:      

Our Free Sample Report includes:

  • Overview & introduction of market study
  • Revenue and CAGR of the market 
  • Drivers & Restrains factors of the market 
  • Major key players in the market 
  • Regional analysis of the market with a detailed graph
  • Detailed segmentation in tabular form of market 
  • Recent developments/news of the market 
  • Opportunities & Challenges of the Market

Some of the Key Market Players:

  • Aurora Cannabis
  • Cresco Labs
  • Jazz Pharmaceuticals
  • Verano Holdings
  • Canopy Growth Corporation
  • Green Thumb Industries
  • Trulieve Cannabis
  • MedMen
  • Aphria
  • Cronos Group
  • Curaleaf
  • GW Pharmaceuticals, plc.
  • The Green Organic Dutchman

To Know More on Market Players, Download a Free Sample Report Here:    

Analyst View:

Global cannabis regulations differ, but most countries are legalizing it fast, thereby creating a multibillion-dollar market with huge growth potential. The market segments include cannabis for recreation and cannabis for medical use. Young people form a huge part of the cannabis users, particularly the millennial group who exhibit a social class influence. Due to early legalization and permissive rules, North America is the leader of the legal cannabis business concerning product variety. The constantly changing process of the market keeps including new and different consumers and substances like CBD or substances for euphoric-balming effects.

Legal Cannabis Market: Report Scope
Report Attributes Details
Market value in 2024 USD 47 Billion 
Market value in 2034 USD 194.5 Billion
CAGR 16.9% from 2024 – 2034
Base year 2023
Historical data 2019-2022
Forecast period 2024-2034

Market Dynamics:



Growing Recognition and Legalization

  • Together, the increasing number of countries legalizing cannabis and the health benefits derived from medical marijuana easily make the global legal cannabis market ripe for significant growth. North America dominates the market due to major contributors such as the US, Canada, the UK, Germany, and Australia. The medicinal properties of cannabis will most probably drive massive growth in the medical cannabis market. Recreational use of marijuana is projected to have the fastest growth rate, and, as such, create jobs and boost the economy. The growth of the market results from geographical expansion, regulatory frameworks, and technological enhancements.

Increasing Customer Requirements

  • It’s the change in consumer expectations that’s driving big shifts in the legal cannabis sector. Companies are rolling out new product lines to cater to health-conscious consumers who demand a wider variety of cannabis-infused products. Where consumers want organically grown and pesticide-free cannabis, quality, and safety also rank very high. Consumers demand personalized experiences, where buyers and dispensaries are very important in guiding clientele to the right products. Moreover, there is an increase in sustainability and social responsibility due to customers valuing companies advocating for them. Technological integration is also being utilized to enhance convenience and engagement measures.

Request for a Discounted Price on this Report @       

Market Trends:

Benefits of Medicine and Research

  • Growth opportunities in legal cannabis mainly come from the legalization of their consumption, primarily for medical use. There are several medical diseases where the benefits of the use of cannabis have been proved, and the FDA has approved quite a few drugs derived from this plant. Improved cultivation, extraction, and testing technologies are also able to raise the quality and safety of products. The medicinal properties of cannabis are also opening up new options in treatment today, especially with those disorders resistant to traditional medications. Growing awareness of the potential economic opportunities that cannabis avails itself to could further drive the development of new innovative products and treatments, thereby accelerating market growth.


Legal Cannabis Market is segmented based on Source, Compound, Products, and Region.

Source Insights

  • From the flowers, which have classically been the traditional form of cannabis for as long as anyone can remember, to a large collection of strains with different cannabinoid levels, the flower truly captures the capabilities of the plant. Seed oil is another source that is not psychoactive in nature but is popular mainly due to its abundance of vital fatty acids and possible health benefits. Other sources are concentrated and super-potent cannabis products like trichomes, kief, and live resin. The infused product market is bound to grow with rising demand for seed oil. All in all, cannabis continues changing to best accommodate these different types of customers.

Compound Insights

  • Tetrahydrocannabinol is the widest cannabinoid used and has euphoric-balming effects. With increasing education among consumers, it can maintain its market share. One of the non-psychotic components is CBD, which helps in pain management and sleep quality, amongst others. Balanced THC & CBD: This segment caters to customers looking for a balanced experience by balancing the analgesic, relaxing properties of THC with the anxiety-reducing, focused properties of CBD.

Product Insights

  • Cannabis oil is quite often a concentrate, one can administer it topically for pain, consume it right out of the container, or use it in edibles. Cannabis drinks, like coffee, bubbling water, and spiked drinks, offer a more discreet and convenient way of consumption. Cannabis candies and chocolates are also other discreet and controlled ways. The legal cannabis sector is always experimenting with new products, vaporizers, topicals, edibles, baked foods, and sprays. Cannabis is also used for pet treats quite frequently. It is believed to expand the market for edibles as much as consumer acceptability and legalization expand.

Reduce a full report cost up to 30% with a custom report by requesting here:

Recent Development:

  • In July 2024, Hundreds of pro-cannabis advocates took to Bangkok’s streets to protest a possible ban on general use. The Thai government floated plans to relist the plant as a narcotic, two years after it was decriminalized, earlier this year. A health ministry drug control committee approved the proposal, which would see cannabis only allowed for medical and research purposes.
  • In July 2024, NIST’s New Hemp Reference Material Will Help Ensure Accurate Cannabis Measurements. NIST’s Hemp Plant Reference Material will aid labs in accurately measuring THC, CBD, and other compounds in cannabis products, aiding forensic labs in distinguishing between legal hemp and federally controlled marijuana. It will also assist producers and state regulators in ensuring the safe use and accurate labeling of cannabis products.

Regional Insights

  • North America: The charge is currently being led from North America, due to early legalization and relatively permissive laws in countries like Canada and a number of US states. With so many goods on offer against the backdrop of a clientele base very loyal to their products, almost everything is put in place to create an almost perfect environment. The growth of the North American legal cannabis business is aided by many things, especially the medicinal and recreational markets, consumer demand, and lastly, medicinal research. The largest players are represented by Canopy Growth and Aurora Cannabis. The country with the most rapid growth relocated to Canada.
  • Asia Pacific: Asia is increasingly tolerating the use of medical marijuana, mainly in South Korea and Thailand, the growing disposable money of relatively less developed countries at large will set the stage for marijuana legalization for recreational use when regulations change.

Browse Detail Report on “Legal Cannabis Market Size, Share, By Source (Flowers, Seed oil, others), By Compound (Tetrahydrocannabinol, Cannabidiol, Balanced THC & CBD), By Product (Cannabis Oil, Cannabis Beverages, Cannabis Chocolates & Gummies, Others) By Application (Medical, Scientific, Industrial, and Horticultural purposes) and Region – Trends, Analysis and Forecast till 2034” with complete TOC @

Browse More Research Reports:

Frozen Food Market Size & Share Report, 2024-2034

Single Jersey Circular Knitting Machines Market Size & Share Report, 2024-2034

Concrete Admixtures Construction Chemical Market Size & Share Report, 2024-2034


Building Applied Photovoltaics Market Size & Share Report, 2024-2034

Cable Protection Market Size & Share Report, 2024-2034

About Us:

Prophecy Market Insights is a specialized market research, analytics, marketing, and business strategy, and solutions company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. Also, we help our client to address business challenges and provide the best possible solutions to overcome them and transform their business.

Prophecy’s expertise area covers products, services, latest trends, developments, market growth factors, and challenges along with market forecasts in various business areas such as Healthcare, Pharmaceutical, Biotechnology, Information Technology (IT), Automotive, Industrial, Chemical, Agriculture, Food and Beverage, Energy, and Oil and Gas. We also offer various other services such as data mining, information management, and revenue enhancement suggestions.


Contact Us:

Prophecy Market Insights

US: 964 E. Badillo Street

#2042 Covina,

CA 91724


US toll-free: +1 860 531 2574

Rest of World: + 91 7775049802

Follow us on: LinkedIn | Twitter

Continue Reading


Global CBD Oil Market Size To Exceed USD 26.72 Billion By 2033 | CAGR of 18.36%



New York, United States , July 09, 2024 (GLOBE NEWSWIRE) — The Global CBD Oil   Market Size Expected to Grow from USD 4.95 Billion in 2023 to USD 26.72 Billion by 2033, at a CAGR of 18.36% during the forecast period 2023-2033.

Get a Sample PDF Brochure:

Cannabidiol oil is another name for CBD oil. (CBD), which originates from cannabis plants, such as hemp and marijuana, can possess anxiolytic, anti-inflammatory, and analgesic properties. These characteristics have led to research on CBD oil as a possible treatment for a number of diseases, including anxiety disorders, chronic pain, and epilepsy. The demand for CBD-infused beauty and skincare products has surged, indicating consumers’ growing inclination towards natural and comprehensive skincare treatments. Growing amounts of CBD, which is well-known for its potential anti-inflammatory and antioxidant properties, are being added to skincare formulae to address issues including acne, inflammation, and aging. Governments from a number of states and countries are supporting its use in drugs and other medical treatments, which is expected to expand and increase these products’ sales and distribution throughout the course of the projected period. However, manufacturers continue to work to increase awareness among customers and provide informative packaging to make it clear what the consumer wants to get out of the items. Consequently, the attempts to support the marketing operations may present opportunities for the global cannabidiol oil market.  

Browse key industry insights spread across 232 pages with 110 Market data tables and figures & charts from the report on the “Global CBD Oil Market Size, Share, and COVID-19 Impact Analysis, By Source (Marijuana, Hemp), By Product (Full-Spectrum CBD Oil, Broad-Spectrum CBD Oil, CBD Isolate), By Application (Food & Beverages, Pharmaceuticals, Pet Care, Cosmetics, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033″

Buy Now Full Report:


The hemp segment is expected to hold the largest share of the CBD oil market during the anticipation timeframe.   

Based on the source, the CBD oil market is categorized into marijuana, and hemp. Among these, the hemp segment is expected to hold the largest share of the CBD oil market during the anticipation timeframe. Increased demand for pharmaceuticals and increased public awareness of health issues are likely to drive significant growth in the market for hemp-derived cannabidiol. The pharmaceutical industry predicts that when consumer disposable income increases and cannabis becomes legal, demand for the substance will rise.

The full-spectrum CBD oil segment is expected to grow at the fastest CAGR during the anticipation timeframe.    

Based on the product, the CBD oil market is categorized into full-spectrum CBD oil, broad-spectrum CBD oil, and CBD isolate. Among these, the full-spectrum CBD oil segment is expected to grow at the fastest CAGR during the anticipation timeframe. It indicates the combined benefits of many drugs may be more beneficial than CBD individually. With regard to the entourage effect, full-spectrum CBD oil is expected to have more medicinal benefits than CBD isolation. People may get improved relief from symptoms like pain, inflammation, anxiety, and more.

The pharmaceuticals segment is expected to hold a significant share of the CBD oil market   during the anticipation timeframe.


Based on the application, the CBD oil market is categorized into food & beverages, pharmaceuticals, pet care, cosmetics, and others. Among these, the pharmaceuticals segment is expected to hold a significant share of the CBD oil market during the anticipation timeframe. the growing number of research investigations evaluating CBD’s physical effects on particular medical conditions. These products are used as an alternative by a substantial, knowledgeable, and conscientious consumer base to lessen mental stress and nervousness.

Inquire Before Buying This Research Report:

North America is projected to hold the largest share of the CBD oil market over the anticipation timeframe.

North America is projected to hold the largest share of the CBD oil market over the anticipation timeframe. Interest from consumers in and tolerance to CBD have significantly increased in the US, which has significantly affected the market share and position of the area. North America is currently the largest market region because to ongoing development, pre-existing infrastructure, and growing public awareness of the potential benefits of CBD.

Europe is expected to grow at the fastest CAGR growth of the CBD oil market during the anticipation timeframe. The legalization of cannabis in a number of European countries has created new markets for CBD products, which will attract investment and encourage the creation of new goods. Moreover, the rise of CBD-infused goods in industries like wellness, food and drink, healthcare, and cosmetics encourages market progress in Europe and positions the region as a significant CBD oil market over the projection period.


Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the CBD oil market are Aurora Cannabis Inc., BIOTA Biosciences LLC, CannazALL, Cannoid LLC, Canopy Growth Corp., CBD American Shaman LLC, CV Sciences Inc., Elixinol, Avicanna, Endoca BV, Folium Biosciences, Gaia Botanics, Green Roads Inc., Happie Hemp Pvt. Ltd., Kazmira LLC, Medical Marijuana Inc., and others.

Get Discount At @

Recent Developments

  • On January 2023, the acquisition of Goodbody Botanicals Ltd. by British Cannabis, a pioneer in the CBD market, represents a major advancement in our leadership in the wellness industry. This acquisition represents a significant expansion of our manufacturing capacity and an improvement in our ranking on the UK Food Standards Agency’s (FSA) list of authorized products, signifying more than just the joining of two firms.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the CBD oil market based on the below-mentioned segments: 


Global CBD Oil Market, By Source

  • Marijuana
  • Hemp

Global CBD Oil Market, By Product

  • Full-Spectrum CBD Oil
  • Broad-Spectrum CBD Oil
  • CBD Isolate

Global CBD Oil Market, By Application

  • Food & Beverages
  • Pharmaceuticals
  • Pet Care
  • Cosmetics
  • Others

Global CBD Oil Market, By Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Browse Related Reports

Global Resuscitation Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (External Defibrillators, Airway Management Devices, Convective Warming Blankets, and Other Resuscitation Devices), By Patient Type (Adult Patients, and Pediatric Patients), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Centers, Pre-Hospital Care Settings and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033          

Global Tissue Diagnostics Market Size, Share, Growth Analysis, By Product (Consumables, and Instrument), By Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology & Workflow, and Special Staining), By Application (Breast Cancer, Prostate Cancer Gastric Cancer, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Global Smart Pills Market Size, Share, and COVID-19 Impact Analysis, By Target Area (Esophagus, Small Intestine, Large Intestine, and Stomach), By Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), By End User (Hospital, Diagnostic Center, Research Institute, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global LASIK Eye Surgery Market Size, Share, and COVID-19 Impact Analysis, By Type (Wavefront Optimized, Wavefront-Guided, Topography-Guided, and All Laser), By End-User (LASIK Eye Centers, Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033


About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements. 


For More Information on Your Target Market, Please Contact Us Below:    


Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)


Contact Us:

Follow Us: LinkedIn | Facebook | Twitter


Continue Reading

Latest news

Trending on Grassnews Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with

Contact us:

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania